Antibody based drugs, including IgG monoclonal antibodies, are an expanding class of
therapeutics widely employed to treat cancer, autoimmune and infectious diseases. IgG …

The inability of antibodies to penetrate the blood-brain barrier (BBB) is a key limitation to
their use in diverse applications. One promising strategy is to deliver IgGs using a bispecific …

Droplet microfluidics has become a very powerful tool in high-throughput screening,
including antibody discovery. Screens are usually carried out by physically sorting droplets …

Despite their common use in research, monoclonal antibodies are currently not
systematically sequenced. This can lead to issues with reproducibility and the occasional …

Monoclonal antibodies are becoming increasingly important for molecular immunology
research. It has also become key components in a wide variety of clinical laboratory …